Research and Markets: PharmaPoint: Chronic Heart Failure - Global Drug ... Wall Street Journal The chronic heart failure (CHF) market is a mature market that has been slowly overtaken by generic drugs, and more branded products are expected to lose market exclusivity during the next few years. The authors predict that the major global barriers ... |
